SCHEMBL8874209

SCHEMBL8874209

COc1ccc2ccc3ccn(CCN)c3c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.46
HTR2A P28223 3/20 0.46
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ADRB2 P07550 1/20 0.43
MTNR1A P48039 7/20 0.41
MTNR1B P49286 6/20 0.41
HTR7 P34969 2/20 0.40
TXNRD1 Q16881 1/20 0.38
TXNRD3 Q86VQ6 1/20 0.38
TXNRD2 Q9NNW7 1/20 0.38
HASPIN Q8TF76 2/20 0.38
DYRK2 Q92630 2/20 0.38
DYRK3 O43781 1/20 0.38
CLK1 P49759 1/20 0.38
CLK2 P49760 1/20 0.38
CLK3 P49761 1/20 0.38
GSK3B P49841 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8875730 0.89 MTNR1A (0.42) HTR2CHTR2AMTNR1AMTNR1BDYRK1A
Fumaric Acid SCHEMBL8875723 0.89 MTNR1A (0.42) HTR2CHTR2AMTNR1AMTNR1BDYRK1A
SCHEMBL8596238 0.80 HTR2C (0.66) HTR2CHTR2A
SCHEMBL8596900 0.80 HTR2C (0.66) HTR2CHTR2A
SCHEMBL6803161 0.78 HTR2C (0.63) HTR2CHTR2AMAPTKDM4EMEN1
SCHEMBL8874163 0.78 MTNR1A (0.72) HTR2CMTNR1AMTNR1B
SCHEMBL19187660 0.75 HTR2C (0.41) HTR2CHTR2AMAPTKDM4EMEN1
Fumaric Acid SCHEMBL8874855 0.72 HTR2C (0.54) HTR2CHTR2AMTNR1AMTNR1B
Fumaric Acid SCHEMBL8873554 0.72 HTR2C (0.54) HTR2CHTR2AMTNR1AMTNR1B
Fumaric Acid SCHEMBL8873561 0.72 HTR2C (0.54) HTR2CHTR2AMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646173-A ANTISEROTONINE AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS; ANTIDEPRESSANTS HOFFMANN-LA ROCHE INC. (US) 1997-07-08 US disclosed
EP-0657426-A2 Tricyclic pyrrole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1995-06-14 EP disclosed